Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Topical ESR-114 in Subjects With Plaque Psoriasis [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update on ESR-114 topical treatment for psoriatic plaque, completed phases 1 and 2 assessing safety, pharmacokinetics, and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis
• Psoriatic Plaque

Drugs mentioned

• ESR-114

Snippet

Sponsor: Escalier Biosciences B.V. | Conditions: Psoriatic Plaque | Phase 1, Phase 2 | Status: COMPLETED